Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic immunization: what's in a name?

Stephen Albert Johnston1, Adel M Talaat, Michael J McGuire

  • 1Center for Biomedical Inventions, University of Texas--Southwestern Medical Center, Dallas, TX 75390-8573, USA. Stephen.Johnston@utsouthwestern.edu

Archives of Medical Research
|September 18, 2002
PubMed
Summary

Genetic immunization (GI) shows promise for creating protective immune responses, overcoming previous limitations in antibody production and the simian barrier. Further exploration of its potential in manipulating the immune system is key for broader applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superior protection against tuberculosis using heterologous mRNA nanoadjuvant vaccines.

NPJ vaccines·2026
Same author

Comparative transcriptomic signatures of virulent and attenuated <i>Mycobacterium bovis</i> growing <i>in vitro</i> and in mice.

Frontiers in cellular and infection microbiology·2025
Same author

High-sensitivity multicancer detection of stage 1 cancer in dogs.

American journal of veterinary research·2025
Same author

Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs.

Journal of the American Veterinary Medical Association·2024
Same author

Drug resistance and genomic variations among Mycobacterium tuberculosis isolates from The Nile Delta, Egypt.

Scientific reports·2024
Same author

E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection.

Journal of leukocyte biology·2024

Area of Science:

  • Vaccinology
  • Immunology
  • Biotechnology

Background:

  • Genetic immunization (GI) emerged in 1992 as a novel vaccinology approach.
  • GI has demonstrated success in various models and human clinical trials.
  • Current perceptions suggest limitations in antibody production and efficacy in primates/humans (simian barrier).

Purpose of the Study:

  • To address the perceived limitations of genetic immunization.
  • To highlight the potential of GI in eliciting protective immune responses.
  • To propose that underutilization of immune system manipulation contributes to perceived GI limitations.

Main Methods:

  • Review of existing literature on genetic immunization.
  • Analysis of recent reports on overcoming GI limitations.

Related Experiment Videos

  • Conceptual framework for understanding GI potential.

    • Main Results:

    • Recent studies show improved GI efficacy in humans, addressing antibody production and simian barrier issues.
    • Evidence suggests GI can induce protective immune responses in humans.
    • The term "DNA immunization" may inaccurately represent the full potential of gene vaccines.

    Conclusions:

    • Perceived limitations of genetic immunization may stem from underutilization of its immune-modulating capabilities.
    • Re-evaluating the approach beyond "DNA immunization" is crucial.
    • Genetic immunization holds significant potential for developing effective vaccines.